Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS

Clinical trial NCT04810611 · TERMINATED

Trial details

NCT number: NCT04810611
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2021-06-18
Primary completion: 2024-04-19
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.